Patents by Inventor Torsteinn ERLINGSSON

Torsteinn ERLINGSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED TRIPEPTIDES FOR USE IN THE TREATMENT OF A NON-ENVELOPED VIRUS INFECTION
    Publication number: 20240390451
    Abstract: The invention described herein relates to modified tripeptides, in particular LTX-109, for use in the treatment of non-enveloped virus infections.
    Type: Application
    Filed: September 21, 2022
    Publication date: November 28, 2024
    Inventors: Christian LÜTKEN, Johnny Ivar RYVOLL, Torsteinn ERLINGSSON
  • COMPOUNDS FOR USE IN THE TREATMENT OF AN ENVELOPED VIRUS INFECTION
    Publication number: 20240156893
    Abstract: The present invention provides a compound for use in the treatment of an enveloped virus infection in a subject, wherein said compound is a compound of Formula (I) as defined herein: AA-AA-AA-X-Y-Z (I). The invention further provides a method of treating an enveloped virus infection in a subject, which method comprises administering to a subject in need thereof an effective amount of a compound of Formula (I).
    Type: Application
    Filed: March 18, 2022
    Publication date: May 16, 2024
    Applicant: PHARMA HOLDINGS AS
    Inventors: Christian LÜTKEN, Johnny Ivar RYVOLL, Torsteinn ERLINGSSON
  • COMPOUNDS FOR USE IN THE TREATMENT OF SINUSITIS, PNEUMONIA OR OTITIS
    Publication number: 20240148819
    Abstract: The present invention provides a compound for use in the treatment of sinusitis, pneumonia or otitis in a subject, wherein said compound is a compound of Formula (I) as defined herein: AA-AA-AA-X—Y—Z (I). The invention further provides a method of treating sinusitis, pneumonia or otitis in a subject, which method comprises administering to a subject in need thereof an effective amount of a compound of Formula (I).
    Type: Application
    Filed: March 18, 2022
    Publication date: May 9, 2024
    Applicant: PHARMA HOLDINGS AS
    Inventors: Christian LÜTKEN, Johnny Ivar RYVOLL, Torsteinn ERLINGSSON